NCT01763320View on ClinicalTrials.gov

China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis

PHASE3CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

March 5, 2014

Primary Completion Date

November 10, 2016

Study Completion Date

November 10, 2019

Conditions
Ischemic Stroke
Interventions
PROCEDURE

Intracranial stenting group

all the participants in this group will be performed with intracranial stenting

DRUG

medical group

all the participants in this group will be given medical therapy including aspirin 100mg + clopidogrel 75mg per day for 90 consecutive days and clopidogrel 75mg per day thereafter

Trial Locations (1)

100053

Department of neurosurgery, Xuanwu hospital, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT01763320 - China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis | Biotech Hunter | Biotech Hunter